Synerga® is a cell- and protein-free preparation obtained from the metabolic products of the Escherichia coli strain Laves.

Synerga® is a mucous membrane therapeutic with anti-inflammatory and immunoregulatory effects. The site of action is the mucosa as immunological unit.

As it contains no living organisms, it is not a means of symbiotic control and therefore not used for direct build-up of the bacterial flora of the intestine. However, a healthy mucosa is an important prerequisite for the natural bacterial flora to settle there.

Synerga® can help an inflamed intestinal mucosa to regenerate. It therefore acts as a mucosal and immune therapeutic. In contrast to conventional bacteria preparations, in the production of Synerga® proteins, endotoxins, nucleic acids, and insoluble cell wall components are removed. All these are substances that can trigger or aggravate allergic reactions. Moreover, Synerga® contains no artificial flavours and is therefore particularly suitable for the treatment of patients with allergies and / or eczema.